Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma

Published:2006 Issue:23 Volume:12 Page:3707
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Dettmer Arne

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference38 articles.

1. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

2. Sturm JW, Keese MA, Bönninghoff RG, Wüstner M, Post S. [Locally ablative therapies of hepatocellular carcinoma]. Onkologie 2001;24 Suppl 5:35-45.

3. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials

4. Head HW, Dodd GD 3rd. Thermal ablation for hepatocellular carcinoma. Gastroenterology 2004;127:S167-S178.

5. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004;127:S159-S166.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of starch microspheres and nanoparticles in pharmaceutical applications;Starch in Food;2024

2. Chemoembolization with Degradable Starch Microspheres (DSM-TACE): expanding indications in HCC multidisciplinary tumor board;Hepatoma Research;2023

3. Subsequent Ultrasound Vascular Targeting Therapy of Hepatocellular Carcinoma Improves the Treatment Efficacy;Biology;2021-01-22

4. Modern methods of ablation of malignant tumors of the liver;Research'n Practical Medicine Journal;2018-12-22

5. HCC;Locoregional Tumor Therapy;2018